Black Diamond Therapeutics, Inc. ($BDTX)
Filing Information
| Accession Number | 0001193125-26-277553 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 22, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
8,961
Total Value
$14,875.26
P&L
+5.4% (+$806.49)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 19, 2026 | Grant/Award | 8,961 | $1.66 | $14,875.26 | 102,529 | Direct | โ | View Details |